Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Incyte and Novartis join coronavirus efforts with phase 3 study
Ruxolitinib helps to inhibit immune cells from attacking the body’s own immune system
Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
Phase 1 trial was initiated in record time, after vaccine candidate fast-tracked by US government
Merck’s Keytruda beats chemo in first-line colorectal cancer
Achieved “clinically meaningful” improvement in progression-free survival
OSE lung cancer vaccine clears phase 3 hurdle, but COVID-19 stalls programme
Tedopi is aimed at stimulating T-lymphocytes against tumours
Articles
-
Current and future trends for developing digital medical communicationsEvolving digital trends and user needs
-
Q&A: Kate PaxtonPME interview's JPA Health's senior VP
-
Pharma funding and M&A in 2020Why pharma M&A has continually bucked the trend
-
Start small but think bigExploring the potential of agility in unlocking creativity
-
The global antibiotic crisis: a 2020 perspectiveA report from the CDC says the ‘approaching’ post-antibiotic era is already here
Pharmaceutical Market Europe - March 2020
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
BMS and bluebird bio file ide-cel CAR-T for multiple myeloma in US
Ide-cel has breakthrough designation from the FDA
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
The march to sustainability
How sustainability can be achieved within the pharma sector and the critically important role of the communicator
COVID-19 Updates and Daily News
Featured jobs
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Manager (PR)
-
Great Benefits
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Director
-
£Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
-
Senior Account Manager
-
Salary TBC
- FDA grants emergency authorisation to chloroquine for COVID-19
- New study identifies drugs that are safe to use in COVID-19 treatment
- UPDATED: Gilead drops remdesivir’s orphan drug designation
- Sanofi doses first patient in global Kevzara COVID-19 trial
- Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19
- Germany's coronavirus infections climb but deaths remain low
- Incyte and Novartis join coronavirus efforts with phase 3 study
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- Merck’s Keytruda beats chemo in first-line colorectal cancer
- “Fake News” and Credibility in Medical Publishing
- How Much Does Each Advisor “Insight” Actually Cost?
- It's not just our logo that's green
PMHub
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...
Latest intelligence
- “Fake News” and Credibility in Medical Publishing
- Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
- Pharma funding and M&A in 2020
- Why pharma M&A has continually bucked the trend...
Quick links
Infographics
